NSE · JAGSNPHARM
Jagsonpal Pharmaceuticals Limited
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#1,325
of 5,096 stocks
▲ 221W
Peak #1,323 · 27 Sep 2026
Jagsonpal Pharmaceuticals Limited is a smallcap company in the Healthcare space and remains firmly promoter-controlled, with promoters holding 69%, is growing revenue modestly, and commands a premium earnings multiple.
Market Cap
1,586.88 Cr
P/E Ratio
37.66
P/B Ratio
5.84
ROE
15.60%
ROCE
21.02%
Dividend Yield
1.66%
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | 82.23 Cr | 64.20 Cr | 72.94 Cr | 74.46 Cr |
| Net Profit | 13.19 Cr | 8.76 Cr | 10.95 Cr | 12.57 Cr |
| EPS | 2.00 | 1.25 | 1.67 | 1.88 |
| Operating Profit | 17.93 Cr | 12.01 Cr | 16.86 Cr | 17.08 Cr |
Shareholding pattern
Promoter
69.05%
Public
30.95%
Mutual fund holdings
₹0.02
Cr total
2
Schemes
2
Fund Houses
₹0.02 Cr
Total Exposure
Motilal Oswal Mutual Fund₹0.01 Cr (65.0%)
Bandhan Mutual Fund₹0.01 Cr (35.0%)
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 04 Sep 2026 | Dividend | Dividend - Rs 4 Per Share |
| 04 May 2026 | Buyback | Buy Back |
| 12 Sep 2025 | Dividend | Dividend - Rs 2.50 Per Share |
| 08 Jan 2025 | Split | Face Value Split (Sub-Division) - From Rs 5/- Per Share To Rs 2/- Per Share |
| 06 Sep 2024 | Dividend | Dividend - Rs 5 Per Share |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.